Kiniksa Pharmaceuticals International, plc
KNSA
Rang în acțiuni
#2999
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company,... Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobulin G2 monoclonal antibody, which is Phase 2/3 clinical trial for the treatment of recurrent pericarditis; and KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody, which is in pre-clinical stage. The company was formerly known as Kiniksa Pharmaceuticals, Ltd. and changed its name to Kiniksa Pharmaceuticals International, plc in June 2024. Kiniksa Pharmaceuticals International, plc was incorporated in 2015 and is based in London, the United Kingdom.
Preț acțiune
$79.35
Capitalizare de piață
$6.19B
Schimbare (1 zi)
0.97%
Schimbare (1 an)
105.36%
Țară
GB
Tranzacționează Kiniksa Pharmaceuticals International, plc (KNSA)
Categorie
Healthcare
EPS pentru Kiniksa Pharmaceuticals International, plc (KNSA)
EPS la data de June 2026 TTM: $1.07
Conform celor mai recente rapoarte financiare și prețului acțiunilor Kiniksa Pharmaceuticals International, plc, EPS-ul actual al companiei (TTM) este $1.07. La sfârșitul anului 2023, compania avea un EPS de $0.20 o scădere comparativ cu EPS-ului din 2022, care a fost de $2.64.
Istoricul EPS pentru Kiniksa Pharmaceuticals International, plc din 2016 până în 2026
EPS la sfârșitul fiecărui an
| An | EPS | Schimbă |
|---|---|---|
| 2026 (TTM) | $1.07 | -278.33% |
| 2024 | $-0.60 | -400.00% |
| 2023 | $0.20 | -92.42% |
| 2022 | $2.64 | -214.78% |
| 2021 | $-2.30 | -11.88% |
| 2020 | $-2.61 | -12.71% |
| 2019 | $-2.99 | -14.33% |
| 2018 | $-3.49 | 74.50% |
| 2017 | $-2.00 | 170.27% |
| 2016 | $-0.74 | 0.00% |
EPS pentru companii similare sau concurente
| Companie | EPS | Diferență EPS | Țara |
|---|---|---|---|
| $2.41 | 125.23% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $0.02 | -98.24% |
HK
|
